Literature DB >> 2166817

The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function.

C H Yuh1, L P Ting.   

Abstract

Previous studies have identified an enhancer (enhancer I) at nucleotides (nt) 1074 to 1234 in the genome of the human hepatitis B virus (HBV), which locates immediately upstream from the X gene. By analysis of the expression of the chloramphenicol acetyltransferase gene driven by a heterologous simian virus 40 early promoter, we describe the identification of a second enhancer (enhancer II) at nt 1636 to 1741, which locates downstream of enhancer I and immediately upstream of the core gene. With various deletions at the 5' end of enhancer II, a positive regulatory element was identified at nt 1636 to 1690 (the II-A element), with the 5' boundary between nt 1636 and 1671. The II-A element alone did not have an enhancer function, but the enhancer activity was achieved by the concomitant presence of the sequence from nt 1704 to 1741 (the II-B element). The II-B element alone did not have enhancer activity. These results indicate that cooperation between the II-A and II-B elements is required to exhibit the enhancer activity of enhancer II. We also show that enhancer II stimulates the transcriptional activity of both the SPI and SPII promoters of the surface gene. Therefore, the SPI promoter activity is regulated by the proximal HNF-1 binding element and the distal enhancers I and II. These results indicate that multiple regulatory elements scattered over the whole viral genome are involved in the regulation of expression of each individual HBV gene and that the same regulatory element controls the expression of different HBV genes. The relative positions of these regulatory elements in the HBV genome suggest that they may control the expression of HBV genes in a coordinate and cooperative manner.

Entities:  

Mesh:

Year:  1990        PMID: 2166817      PMCID: PMC247894          DOI: 10.1128/JVI.64.9.4281-4287.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Fine-structure mapping of the three mouse alpha-fetoprotein gene enhancers.

Authors:  R Godbout; R S Ingram; S M Tilghman
Journal:  Mol Cell Biol       Date:  1988-03       Impact factor: 4.272

2.  Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

Authors:  J Summers; W S Mason
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

3.  The gene S promoter of hepatitis B virus confers constitutive gene expression.

Authors:  Y Malpièce; M L Michel; G Carloni; M Revel; P Tiollais; J Weissenbach
Journal:  Nucleic Acids Res       Date:  1983-07-11       Impact factor: 16.971

4.  Structural relationships between minor and major proteins of hepatitis B surface antigen.

Authors:  W Stibbe; W H Gerlich
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

5.  Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence.

Authors:  F Galibert; T N Chen; E Mandart
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

6.  Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line.

Authors:  D P Aden; A Fogel; S Plotkin; I Damjanov; B B Knowles
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

7.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

8.  Signals regulating hepatitis B surface antigen transcription.

Authors:  R Cattaneo; H Will; N Hernandez; H Schaller
Journal:  Nature       Date:  1983 Sep 22-28       Impact factor: 49.962

9.  Induction of plasma protein secretion in a newly established human hepatoma cell line.

Authors:  C Chang; Y Lin; T W O-Lee; C K Chou; T S Lee; T J Liu; F K P'eng; T Y Chen; C P Hu
Journal:  Mol Cell Biol       Date:  1983-06       Impact factor: 4.272

10.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

View more
  37 in total

1.  Transcriptional repression of human hepatitis B virus genes by a bZIP family member, E4BP4.

Authors:  C K Lai; L P Ting
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Detection of a hepatitis B virus variant with a truncated X gene and enhancer II.

Authors:  R Repp; C Keller; A Borkhardt; A Csecke; S Schaefer; W H Gerlich; F Lampert
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma.

Authors:  Xin Bai; Yu Zhu; Yan Jin; Xia Guo; Gengsun Qian; Taoyang Chen; Jing Zhang; Jinbing Wang; John D Groopman; Jianren Gu; Hong Tu
Journal:  Carcinogenesis       Date:  2010-09-28       Impact factor: 4.944

4.  C/EBP-like proteins binding to the functional box-alpha and box-beta of the second enhancer of hepatitis B virus.

Authors:  C H Yuh; L P Ting
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

5.  Cellular factors controlling the activity of woodchuck hepatitis virus enhancer II.

Authors:  K Ueda; Y Wei; D Ganem
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

Review 6.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

7.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.

Authors:  H Okamoto; F Tsuda; Y Akahane; Y Sugai; M Yoshiba; K Moriyama; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Woodchuck hepatitis virus X protein is required for viral infection in vivo.

Authors:  F Zoulim; J Saputelli; C Seeger
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Repression of enhancer II activity by a negative regulatory element in the hepatitis B virus genome.

Authors:  W Y Lo; L P Ting
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor.

Authors:  A K Raney; H B Le; A McLachlan
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.